Activating α7 nicotinic acetylcholine receptor inhibits NLRP 3 inflammasome through regulation of β‐arrestin‐1
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Aims: To evaluate whether activating α7 nicotinic acetylcholine receptor (α7n AC hR) could inhibit the NOD‐like receptor family, pyrin domain containing 3 (NLRP 3) inflammasome through regulation of β‐arrestin‐1 in monocyte/macrophage system, thus contributing to the control of neuroinflammation. Methods: The protein levels of NLRP 3, caspase‐1 (Casp‐1) p20 and proCasp‐1, interleukin‐1β (IL‐1β) p17 and pro IL‐1β, IL‐18 and pro IL‐18 were measured using Western blotting. The mRNA levels of Casp‐1 and IL‐1β were detected by real‐time PCR (RT‐PCR). The colocalization and interaction of NLRP 3 protein and β‐arrestin‐1 were measured by immunofluorescence staining and immunoprecipitation. Results: The expression of β‐arrestin‐1 was significantly increased and colocalized with CD 45‐positive cells in spinal cord of experimental auto‐immune encephalomyelitis (EAE) mice when compared with the sham mice, which was attenuated by pretreatment with PNU 282987, a specific α7n AC hR agonist. PNU 282987 also significantly inhibited the activation of NLRP 3 inflammasome and thus decreased the production of IL‐1β and IL‐18 both in lipopolysaccharide (LPS)/ATP‐stimulated BV 2 microglia in vitro and spinal cord from EAE mice in vivo, while inverse effects were observed in α7n AC hR knockout mice. Furthermore, overexpression of β‐arrestin‐1 attenuated the inhibitory effect of PNU 282987 on NLRP 3 inflammasome activation in LPS/ATP‐stimulated BV 2 microglia. PNU 282987 inhibited the interaction between β‐arrestin‐1 and NLRP 3 protein in vitro. Conclusions: The present study demonstrates that activating α7n AC hR can lead to NLRP 3 inflammasome inhibition via regulation of β‐arrestin‐1 in monocyte/microglia system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
NLRP3 inflammasome and its inhibitors: a review
Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00262 · Cited by 836
Self-citationAutophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome
Cho, M.-H., Cho, K., Kang, H.-J., Jeon, E.-Y., Kim, H.-S., Kwon, H.-J., Kim, H.-M., Kim, D.-H., & Yoon, S.-Y. (2014) · Autophagy · doi:10.4161/auto.29647 · Cited by 395
Kimura, K., Tanida, M., Nagata, N., Inaba, Y., Watanabe, H., Nagashimada, M., Ota, T., Asahara, S.-I., Kido, Y., Matsumoto, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.032 · Cited by 84
Cited by
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Xu, Z.-Q., Zhang, W.-J., Su, D.-F., Zhang, G.-Q., & Miao, C.-Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-273 · Cited by 60
Self-citationShehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
Teipel, S. J., Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N.-C., Dechent, P., Dobisch, L., Düzel, E., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215196 · Cited by 20
Metadata
- Authors
- Ke, P., Shao, B., Xu, Z., Chen, X., Wei, W., & Liu, C.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2017-09-21
- Volume
- 23
- Issue
- 11
- Pages
- 875-884
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2759874929
- Cited by
- 53
- References
- 5
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.